Friday, October 10, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Akamai Technologies Receives Diverse Analyst Ratings with Varying Price Targets

Elaine Mendonca by Elaine Mendonca
January 19, 2024
in Breaking News
0
COST stock news
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

As of January 19, 2024, Akamai Technologies (NASDAQ: AKAM) has received ratings from 7 analysts, each offering their unique perspective on the company’s performance. These ratings vary from bullish to bearish, providing a comprehensive view of the stock.

The average price target for Akamai Technologies over the next 12 months is $121.29, indicating a potential increase of 13.36% from the previous average price target of $107.00. The high estimate stands at $150.00, while the low estimate is $78.00. This range showcases the diverse opinions among analysts.

Recent analyst actions have included upgrades, downgrades, and adjustments to price targets. Brandon Nispel of Keybanc upgraded the rating to “Overweight,” setting a current price target of $138.00, up from $134.00. Aaron Samuels of Susquehanna expressed a “Positive” rating with a price target of $150.00. Keith Weiss of Morgan Stanley raised the rating to “Equal-Weight,” with a price target of $112.00, up from $102.00. Rishi Jaluria of RBC Capital upgraded the rating to “Sector Perform,” setting a price target of $115.00, up from $97.00. Mark Murphy of JP Morgan downgraded the rating to “Underweight,” with a price target of $78.00, up from $74.00. Lastly, Frank Louthan of Raymond James upgraded the rating to “Outperform,” with a price target of $122.00, up from $115.00.

The latest analyst ratings reveal that there are 8 “Buy” ratings, 12 “Hold” ratings, and 2 “Sell” ratings. This consensus rating results in a classification of “Moderate Buy,” based on 4 buy ratings, 6 hold ratings, and 1 sell rating.

Considering these analyst ratings, the average 12-month price target for Akamai Technologies is $120.10. The range of estimates spans from a high of $150.00 to a low of $78.00, showcasing the disparity in opinions among analysts.

AKAM Stock Shows Strong Momentum and Positive Performance on January 19, 2024

On January 19, 2024, AKAM stock showed promising performances, according to data sourced from CNN Money. The stock was trading near the top of its 52-week range, indicating strong momentum in its price movement. Additionally, it was trading above its 200-day simple moving average, which further supports the positive sentiment surrounding the stock.

One notable aspect of AKAM’s performance on this day was the price change. The shares of AKAM had increased by $0.72 since the market last closed, representing a rise of 0.60%. This indicates that investors were optimistic about the stock and were willing to pay a higher price for it.

Furthermore, AKAM opened at $119.49, which was $0.17 higher than its previous close. This opening price suggests that there was significant demand for the stock at the start of the trading day.

Overall, AKAM stock displayed positive momentum on January 19, 2024. Its trading near the top of its 52-week range and above its 200-day simple moving average indicates that the stock has been performing well in recent times. Additionally, the price change and higher opening price further indicate investor confidence in AKAM. As always, investors should conduct thorough research and analysis before making any investment decisions.

AKAM Stock Shows Promising Growth in Revenue, Net Income, and EPS: January 19, 2024 Performance Analysis

AKAM stock performances on January 19, 2024, have shown promising growth based on the financial data provided. The data reveals positive trends in total revenue, net income, and earnings per share (EPS) for AKAM.

Starting with total revenue, AKAM recorded $3.62 billion in the past year, representing a 4.49% increase compared to the previous year. In the third quarter, the company generated $965.48 million in total revenue, indicating a 3.18% increase since the previous quarter.

Moving on to net income, AKAM reported a net income of $523.67 million in the past year. However, in the third quarter, the net income decreased by 19.64% compared to the previous year, amounting to $160.54 million. Despite the yearly decline, the net income experienced a significant 24.63% increase since the previous quarter.

Examining the earnings per share (EPS), AKAM reported an EPS of $3.26 in the past year. However, in the third quarter, the EPS decreased by 16.97% compared to the previous year, reaching $1.04. Nevertheless, the company experienced a notable 23.41% increase in EPS since the previous quarter.

Considering the overall performance of AKAM stock on January 19, 2024, investors can be optimistic. The company has demonstrated consistent growth in total revenue, despite a slight decrease in net income and EPS on a yearly basis. However, the quarterly figures show a rebound in net income and EPS, indicating that AKAM has made positive strides in its financial performance.

Investors should conduct comprehensive research and analysis before making any investment decisions.

Tags: AKAM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ stocks to buy

JPMorgan Chase A Lucrative Investment Option with Impressive Returns

Finance_Business (2)

Analyst Ratings and Price Targets for Truist Financial A Moderate Level of Optimism

Preformed Line Products Announces Dividend Payout

Recommended

Puma Biotechnology Launches ALISCALung1 Phase II Clinical Trial A Promising Breakthrough in SCLC Treatment

2 years ago
Expeditors of Washington Stock

A Tale of Two Realities: Expeditors International’s Strong Performance Meets Wall Street Skepticism

2 weeks ago
Kraft Heinz Stock

Kraft Heinz Announces Major Corporate Split After Decade of Challenges

1 month ago
FITB stock news

Investment Firm Reduces Holdings in Mettler-Toledo International Despite Strong Q2 Earnings

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Nike Shares Plunge Following Profit Warning

Johnson & Johnson Shares Surge on Regulatory Wins and Upbeat Analyst Outlook

RWE Shares Gain Momentum Following Bullish Analyst Upgrades

Lululemon Shares Face Investor Exodus as Major Stakeholder Exits

GE Aerospace Stock Maintains Impressive Rally Amid Record Performance

T-Mobile US Sends Mixed Signals to Investors

Trending

Marvell Technology Stock
Analysis

Marvell Technology Shares Face Volatility After Impressive Gains

by Andreas Sommer
October 10, 2025
0

Marvell Technology, the specialized semiconductor firm, is currently undergoing a significant price adjustment following a remarkable rally...

Newmont Mining Stock

Newmont Stock Soars as Gold Hits Unprecedented $4,000 Milestone

October 10, 2025
C3.ai Stock

C3.ai Faces Critical Test Amid Mounting Challenges

October 10, 2025
Nike Stock

Nike Shares Plunge Following Profit Warning

October 10, 2025
Johnson & Johnson Stock

Johnson & Johnson Shares Surge on Regulatory Wins and Upbeat Analyst Outlook

October 10, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Marvell Technology Shares Face Volatility After Impressive Gains
  • Newmont Stock Soars as Gold Hits Unprecedented $4,000 Milestone
  • C3.ai Faces Critical Test Amid Mounting Challenges

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com